Researchers at the University of Michigan Comprehensive Cancer Center have received a grant from the Lustgarten Foundation worth $1.5 million for a project focused on using a pancreatic cancer patient's blood sample to determine the best treatments.
News and Events
Recent Releases01/22/2015 - 3:45pm01/19/2015 - 11:00am
Researchers at the University of Michigan Comprehensive Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers.01/15/2015 - 9:15am
New research helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.01/15/2015 - 9:00am
A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.01/06/2015 - 2:00pm
One of the mysteries in cancer biology is how one protein, TGF-beta, can both stop cancer from forming and encourage its aggressive growth. Now, researchers at the University of Michigan Comprehensive Cancer Center have uncovered a key gene that may explain this paradox and provide a potential target for treatment.